Overactive Bladder - Results from #2220

Patient-reported goal achievement after antimuscarinic treatment in patients with overactive bladder symptoms - Abstract July 10, 2012

A multicenter, double-blind, randomized, placebo-controlled trial of the β3-Adrenoceptor agonist solabegron for overactive bladder - Abstract July 10, 2012

Treatment of overactive bladder symptoms beyond antimuscarinics: Current and Future Therapies - Abstract July 5, 2012

The association between overactive bladder and fibromyalgia syndrome: A community survey - Abstract July 4, 2012

Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: An open-label, multicenter, prospective study - Abstract July 3, 2012

Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the Boston Area Community Health (BACH) survey - Abstract July 2, 2012

FDA approves overactive bladder treatment Myrbetriq™ (mirabegron) from Astellas June 29, 2012

Full prescribing information for MYRBETRIQ™ (mirabegron) extended-release tablets, for oral use, indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency June 29, 2012

FDA approves Myrbetriq for overactive bladder June 29, 2012

Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB) - Abstract June 29, 2012

Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention - Abstract June 28, 2012

Association between metabolic syndrome and male overactive bladder in a Japanese population based on three different sets of criteria for metabolic syndrome and the Overactive Bladder Symptom Score - Abstract June 27, 2012

Differences in transverse and longitudinal rat detrusor contractility under K+ channel blockade - Abstract June 27, 2012

Overactive bladder after transurethral resection of prostate treated with electroacupuncture therapy and tolterodine - Abstract June 26, 2012

Phase IIb, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to determine effects of elocalcitol in women with overactive bladder and idiopathic detrusor overactivity - Abstract June 25, 2012

Risk factors for new-onset overactive bladder in older subjects: Results of the Fujiwara-Kyo study - Abstract June 22, 2012

Botox(®) for idiopathic overactive bladder: Efficacy, duration and safety. Effectiveness of subsequent injection - Abstract June 21, 2012

Transcutaneous electrical nerve stimulation: An effective treatment for refractory non-neurogenic overactive bladder syndrome? - Abstract June 20, 2012

High frequency of overlap between functional dyspepsia and overactive bladder - Abstract June 19, 2012

Concepts in the management of the overactive bladder in women - Abstract June 18, 2012

Page 112 of 125